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Introduction
In response to growing demand for life-saving kidney transplants, transplant centers have expanded living kidney donation and relaxed criteria for living donors, allowing older individuals and those with a modest burden of comorbidities to donate. 1 Current studies suggest that these potentially higherrisk donors do not exhibit higher rates of long-term complications; however, long-term complications do develop in some living kidney donors. [2] [3] [4] [5] Complications of chronic illnesses such as hypertension or diabetes can take decades to develop, calling into question whether truly low-risk kidney donors can be reliably identified. Follow-up with kidney donors is minimal, and there are currently no methods by which to identify individuals who will develop long-term complications. 4, 6, 7 All potential kidney donors undergo a comprehensive screening that aims to allow only healthy individuals to undergo donor nephrectomy. These screening methods identify patients with clinically known risk factors such as hypertension or kidney disease. However, among individuals with no clinically known cardiovascular risk, a subset of patients with clinically silent risk factors may exist. 4, 7, 8 Previous studies have validated analytic morphomics, which utilizes preoperative computed tomography (CT) scans as a novel risk stratification tool in various surgical populations. [9] [10] [11] [12] [13] Analytic morphomics may be an especially useful risk stratification tool in living kidney donors because each potential donor undergoes a CT scan as a part of the screening process. Analytic morphomics has not yet been applied to this population and may be able to help identify potential kidney donors who are at greater risk of developing chronic disease following donation.
The purpose of this study is to examine the potential benefit of analytic morphomics as a long-term risk assessment tool in kidney donors.
To this end, we obtained long-term follow-up data from kidney donors at a single large academic institution who donated between 2000 and 2010.
Kidney donors were asked to complete a survey that included questions to specifically target the development of cardiovascular risk factors as well as reflective questions about the quality of their donation experience. Analytic morphomic measurements were determined using predonation CT scans. We hypothesize that predonation morphometric measures in kidney donors without preexisting known comorbidities will be associated with the development of chronic disease.
Methods

Study Population
The study population was limited to individuals who underwent donor nephrectomy between Jan- 
Survey Instrument
Study subjects who agreed to participate con- 
Analytic Morphomics
Aortic calcification, trunk muscle characteristics, and morphometric age are previously validated measures of perioperative outcomes. [9] [10] [11] [12] [13] Aortic calcification was measured on preoperative CT scans using semiautomated methods in MATLAB v13. In brief, the center of the abdominal aorta was first mapped manually between the L1 and L3 vertebrae. Calcification was then defined as having den- among donors who had calcification ranged from 0.10% to 33.9%. As shown in Figure 1 , the distribution of aortic calcification was skewed to the right with a median of 1.70% wall calcification. 
Results
Conclusion
Analytic morphomics has been shown to be a valuable tool for predicting short-and long-term outcomes in a variety of surgical populations. [9] [10] [11] [12] [13] We have explored the utility of analytic morphomics in predicting long-term outcomes in living kidney donors. The composite measure of morphomic risk at the time of donation, morphometric age, is associated with the development There are important limitations of this study. This is a retrospective study and is not designed to attribute causality between analytic morphomics and long-term outcomes in kidney donors. Furthermore, this study is also not designed to attribute adverse long-term outcomes to kidney donation as has been explored by other studies. 18 The results of our study are limited in that our data were collected at a single large academic medical institution that serves as a regional transplant center. 
